By browsing our site you agree to our use of cookies. You will only see this message once. Find out more
We regret to inform you that we have ceased publication of current announcements. domain is for sale. Please contact us.

Pathology Managed Laboratory Service.

Contract award notice


Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

NHS Wales Procurement Services on behalf of Cwm Taf UHB
Prince Charles Hospital
Contact point(s): Procurement Services
For the attention of: Annmarie Pritchard
CF47 9DT Merthyr Tydfil
United Kingdom
Telephone: +44 1685726380

Internet address(es):

General address of the contracting authority:

Address of the buyer profile:

I.2)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local sub-divisions
I.3)Main activity
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: no

Section II: Object of the contract

II.1.1)Title attributed to the contract
Pathology Managed Laboratory Service.
II.1.2)Type of contract and location of works, place of delivery or of performance
Service category No 25: Health and social services
Main site or location of works, place of delivery or of performance: Cwm Taf University Health Board.

NUTS code UK

II.1.3)Information about a framework agreement or a dynamic purchasing system (DPS)
II.1.4)Short description of the contract or purchase(s)

NWSSP Procurement Services ‘the Authority’ on behalf of Cwm Taf University Health Board has undertaken ‘Pre-Market’ Engagement sessions during June 2015 via OJEU Notice 170024-2015 (2015/S 094-170024)issued on 16.5.2015.

Following this notice; which was not a call for competition ‘the Authority’ on behalf of Cwm Taf University Health Board is now seeking to award a contract for the appointment of a Managed Laboratory Service (MLS) Provider.
This opportunity is subject to the Light Touch Regime under Schedule 3; Social and other specific services; Pathology Services of Public Contract Regulations 2015.
The main common Vocabulary (CPV) linked to this procurement is 85111800: Pathology Services, other additional objects 85111810: Blood Analysis services & 85111820: Bacteriological analysis services
It is proposed to run a competitive exercise consisting of 2 stages;
a) Stage 1 - Pre Qualification Questionnaire ‘PQQ’, Service providers will only be invited to ITT submission if they are successfully evaluated at the PQQ stage;
b) Stage 2 - Invitation to tender.
It is the expectation that the ‘Provider’ will provide the provision of and the following ‘service lines’ in an integrated and efficient manner, this may also include an option of transportation of specimens within CTUHB locality. ‘Service lines’ - General Routine Clinical Biochemistry, Immunoassays, Chromatography, Mass spectrometry Electrophoresis (serum & urine), HbA1C, Haematology, Coagulation, Immunology, Blood transfusion, Point of Care testing to include blood glucose and blood ketones, blood gas, automated urinalysis, INR testing, automated pregnancy testing, haemoglobin, HbA1c also to assist in areas of future development through patient self testing.
It is the intention to use the contract awarded as a vehicle to integrate any other future pathology requirements; providing assistance to the Health Board to reach optimum efficiency within the current facilities and any subsequent re-organisation or centralisation that is directed from the Health Board; Regional collaborations and/or Welsh Government. This could include the contract being made available to other Health Board's and Trusts within South Wales; namely Abertawe Bro Morgannwg UHB; Aneurin Bevan UHB; Cardiff & Vale UHB and Velindre NHS Trust, however for clarity at the time of this notice it is only Cwm Taf University Health Board that has the definitive requirement.
It is the intention of the Authority to enter into a VAT efficient contract where costs are eligible for recovery under the Contracted Out Services (‘COS’) regime as a managed pathology services arrangement.
II.1.5)Common procurement vocabulary (CPV)

85111800, 85111810, 85111820

II.1.6)Information about Government Procurement Agreement (GPA)
II.2)Total final value of contract(s)
II.2.1)Total final value of contract(s)
Value: 26 414 614 GBP
Excluding VAT

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure
IV.2)Award criteria
IV.2.1)Award criteria
The most economically advantageous tender in terms of
1. Executive Summary. Weighting 5
2. Peri analytical requirements (pre & post). Weighting 7
3. General Analytical service. Weighting 15
4. Quality requirements and assurances. Weighting 13
5. Computer information systems. Weighting 5
6. Contract delivery. Weighting 15
7. Price (value for money). Weighting 40
IV.2.2)Information about electronic auction
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority
IV.3.2)Previous publication(s) concerning the same contract

Prior information notice

Notice number in the OJEU: 2015/S 094-170024 of 16.5.2015

Contract notice

Notice number in the OJEU: 2015/S 244-443739 of 17.12.2015

Section V: Award of contract

Lot title: Pathology Managed Laboratory Services
V.1)Date of contract award decision:
V.2)Information about offers
Number of offers received: 1
V.3)Name and address of economic operator in favour of whom the contract award decision has been taken

Roche Diagnostics Limited
Charles Avenue
RH15 9RY Burgess Hill
United Kingdom

V.4)Information on value of contract
Total final value of the contract:
Value: 26 414 614 GBP
Excluding VAT
V.5)Information about subcontracting
The contract is likely to be sub-contracted: yes
Value or proportion of the contract likely to be sub-contracted to third parties:
Not known
Short description of the value/proportion of the contract to be sub-contracted: The contract is for the appointment of a Prime Contractor to provide a fully Managed Laboratory Service, which will incorporate CTUHB's Pathology Service lines. This will include managing 3rd party specialist providers.

Section VI: Complementary information

VI.1)Information about European Union funds
VI.2)Additional information:
The total final value of the contract which is GBP 26,414,614 is based upon the ‘Core’ 8 Year contract (GBP 17,609,766) with the additional extention periods of 1+1+1+1 (4 Years). This also includes a predicted growth factor that will be monitored through a robust contract monitoring process.
(WA Ref:67397).
VI.3)Procedures for appeal
VI.3.1)Body responsible for appeal procedures

NWSSSP Procurement Services
Front Line Procurement Services on behalf of Cwm Taf University Health Board, Block 8, Prince Charles Hospital
CF47 9DT Merthyr Tydfil
United Kingdom
Internet address:

VI.3.2)Lodging of appeals

Precise information on deadline(s) for lodging appeals: The Authority will allow a minimum 10 day calendar day standstill period between notifying the award decision and awarding the contract. Unsuccessful bidders and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the bidder/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1). Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules, have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits and must be brought promptly. For more information on how to appeal, and the relevant time limits, please see the following statement on the Authority's website:

VI.3.3)Service from which information about the lodging of appeals may be obtained

NWSSSP Procurement Services
Front Line Procurement Services on behalf of Cwm Taf University Health Board, Block 8, Prince Charles Hospital
CF47 9DT Merthyr Tydfil
United Kingdom
Internet address:

VI.4)Date of dispatch of this notice: